Skip to main content

Find Clinical Trials

Home
Conditions
Hepatitis B

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

458 public trials 28 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

NCT05791851

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +19 more
Locations: Baltimore Veterans Affairs Medical Center Baltimore, Maryland, United States

Institute of Human Virology Baltimore, Maryland, United States

View Trial Details

Completed

Dynamic Liver Tests in Liver Disease

NCT02782247

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +11 more
Locations: Bart's Health NHS London, United Kingdom

View Trial Details

Completed

Accelerated Vaccination Schedule Against Hepatitis B Virus With Combined Hepatitis A and B Vaccine Among Hemodialysis Patients

NCT03149874

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +9 more
Locations: Not specified

View Trial Details

Completed

Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus

NCT02995005

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Shoklo Malaria Research Unit Mae Sot, Thailand

View Trial Details

Completed

An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection

NCT03361956

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: The Office of Franco Felizarta, MD Bakersfield, California, United States

Orlando Immunology Center Orlando, Florida, United States

Rush University Medical Center Chicago, Illinois, United States

Tulane Medical Center (TMC) New Orleans, Louisiana, United States

View all 76 locations

View Trial Details

Completed

Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial Responders

NCT00704106

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Stanford University Medical Center Palo Alto, California, United States

San Jose Gastroenterology San Jose, California, United States

San Jose Gastroenterology San Jose, California, United States

Asian Village Medical Clinic Chicago, Illinois, United States

View Trial Details

Completed

Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya

NCT01878435

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +30 more
Locations: Gem and Asembo Area Gem and Asembo Area, Siaya County, Kenya

View Trial Details

Completed

A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses

NCT02434848

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +14 more
Locations: Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, South Yorkshire, United Kingdom

View Trial Details

Completed

Phase 1 Study of GSK3228836 Pharmacokinetics in Participants With Hepatic Impairment

NCT04971928

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +11 more
Locations: GSK Investigational Site Orlando, Florida, United States

GSK Investigational Site San Antonio, Texas, United States

View Trial Details

Completed

Hepatitis B Challenge Dose in Adults (V232-059-10)

NCT01251276

Conditions: Blood-Borne Infections, Communicable Diseases, DNA Virus Infections, +8 more
Locations: Not specified

View Trial Details